Company Filing History:
Years Active: 2015
Title: Innovations in Hepatoprotection: The Work of Wei-Lii Lin
Introduction: Wei-Lii Lin is a notable inventor hailing from Taichung, Taiwan. With a focus on pharmaceutical innovations, he has made significant contributions to the field, particularly relating to hepatoprotection. His inventiveness is reflected in his patent, which showcases a unique approach to enhancing liver health.
Latest Patents: Wei-Lii Lin holds one patent that is particularly noteworthy. The patent details a pharmaceutical composition that is useful in hepatoprotection. This innovative composition comprises an effective amount of kinsenoside or a pharmaceutically acceptable salt or ester thereof. Furthermore, Lin's patent includes an aqueous extract that is substantially free of ethyl acetate-philic components, marking a significant step forward in hepatoprotective treatments.
Career Highlights: Currently, Wei-Lii Lin is affiliated with China Medical University, where he continues to pursue his research endeavors. His work contributes to advancements in pharmacology and the development of treatments aimed at protecting liver function and health.
Collaborations: Lin collaborates with notable colleagues, including Wen-Chuan Lin and Jin-Bin Wu, who also contribute to research in similar fields. Their combined expertise fosters innovation and enhances the research capabilities at China Medical University.
Conclusion: Wei-Lii Lin exemplifies the spirit of innovation in the pharmaceutical industry, focusing on hepatoprotection through his patented composition. His contributions not only advance the medical field but also support collaborative research efforts that inspire future developments in liver health. His work serves as a testament to the importance of continued innovation in pharmaceuticals and the potential for improved health outcomes.